CD274 and large cell neuroendocrine carcinoma: Although the correlation of PD-1 and PD-L1 expression with response to immune checkpoint inhibitor therapy remains under investigation, the presence of PD-1/PD-L1 in LCNEC is interesting, especially considering the scarcity of treatment options and potential therapeutic targets in this rare and very aggressive malignancy.